As downregulation of MMR system-related genes and MMR deficiency could cause MSI which has been found to predict a good response to PD-1 blockade (35, 36), this effect might contribute to the combination of radiotherapy and immunotherapy in CRC. Here, PDCD1 is linked to colorectal carcinoma.